Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)

Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)

10.1002/pbc.20684

Saved in:
Bibliographic Details
Main Authors: Kwok, C.S., Kham, S.K., Quah, T.C., Yeoh, A.E., Ariffin, H., Lin, H.P.
Other Authors: PAEDIATRICS
Format: Article
Published: 2011
Subjects:
ALL
Drug efficacy
L-asparaginase
Leukemia
Minimal residual disease
Online Access:http://scholarbank.nus.edu.sg/handle/10635/25684
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1002/pbc.20684

Similar Items